Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Amy C. Brown, Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J. Craig, Klaus Dragull, Arieh M. Levine & Jonathan D. Baker. (2007) Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clinical Toxicology 45:5, pages 549-556.
Read now
Read now
T. Teramura, T. Watanabe, S. Higuchi & K. Hashimoto. (1995) Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human. Xenobiotica 25:11, pages 1237-1246.
Read now
Read now
A. G. Renwick. (1993) Data‐derived safety factors for the evaluation of food additives and environmental contaminants. Food Additives & Contaminants 10:3, pages 275-305.
Read now
Read now
Sergey V. Geodakyan. (1993) Methodological Approach in the Study of Anticancer Drug Metabolism: Qualitative Considerations. Drug Metabolism Reviews 25:1-2, pages 153-172.
Read now
Read now
A. G. Renwick. (1991) Safety factors and establishment of acceptable daily intakes. Food Additives & Contaminants 8:2, pages 135-149.
Read now
Read now
Dennis A. Smith. (1991) Species Differences in Metabolism and Pharmacokinetics: Are We Close to an Understanding?. Drug Metabolism Reviews 23:3-4, pages 355-373.
Read now
Read now
M. Pellegatti, P. Grossi, J. Ayrton, G. L. Evans & A. J. Harker. (1990) Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog. Xenobiotica 20:8, pages 765-777.
Read now
Read now
B. K. Park & N. R. Kitteringham. (1990) Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications. Xenobiotica 20:11, pages 1171-1185.
Read now
Read now
S. Terashita, Y. Tokuma, M. Sekiguchi & H. Noguchi. (1989) Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats. Xenobiotica 19:11, pages 1221-1229.
Read now
Read now
T. Niwa, Y. Tokuma & H. Noguchi. (1988) Oxidation of nilvadipine, a new dihydropyridine calcium antagonist, to the corresponding pyridine by rat liver microsomes. Xenobiotica 18:2, pages 217-224.
Read now
Read now
Articles from other publishers (9)
Toshiro SakaiKazuhiro SakoMasahiro Hayashi. (2011) Factors Affecting the Absorption of Nilvadipine from Disintegration-Controlled Matrix Tablet in Dogs. Biological and Pharmaceutical Bulletin 34:11, pages 1731-1736.
Crossref
Crossref
Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Satoshi Ueda, Yuji Tokunaga, Rinta Ibuki, Kazutaka Higaki & Toshikiro Kimura. (2006) Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation. Journal of Controlled Release 112:1, pages 51-56.
Crossref
Crossref
Shahab Bohlooli, Fariborz Keyhanfar & Massoud Mahmoudian. (2004) Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats. Biopharmaceutics & Drug Disposition 25:4, pages 187-191.
Crossref
Crossref
Daniel Paris, Amita Quadros, James Humphrey, Nikunj Patel, Robert Crescentini, Fiona Crawford & Michael Mullan. (2004) Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice. Brain Research 999:1, pages 53-61.
Crossref
Crossref
Toshihiro Wajima, Kazuya Fukumura, Yoshitaka Yano & Takayoshi Oguma. (2003) Prediction of Human Pharmacokinetics from Animal Data and Molecular Structural Parameters using Multivariate Regression Analysis: Oral Clearance. Journal of Pharmaceutical Sciences 92:12, pages 2427-2440.
Crossref
Crossref
Stefan Russmann, Yann Barguil, Pierre Cabalion, Marina Kritsanida, Daniel Duhet & Bernhard H Lauterburg. (2003) Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. European Journal of Gastroenterology & Hepatology 15:9, pages 1033-1036.
Crossref
Crossref
Iftekhar Mahmood. (2002) Interspecies Scaling: Predicting Oral Clearance in Humans. American Journal of Therapeutics 9:1, pages 35-42.
Crossref
Crossref
Toshiharu Sakai, Toshio Teramura, Hideaki Okamiya & Osamu Inagaki. (2007) A Review on Barnidipine: A Novel Calcium Antagonist. Cardiovascular Drug Reviews 15:4, pages 273-290.
Crossref
Crossref
Yoji Tokuma & Hideyo Noguchi. (1995) Stereoselective pharmacokinetics of dihydropyridine calcium antagonists. Journal of Chromatography A 694:1, pages 181-193.
Crossref
Crossref